An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity.
HLA
T cells
delayed hypersensitivity reaction
drug allergy
enzyme linked ImmunoSpot (ELISpot)
lymphocyte transformation test (LTT)
severe cutaneous adverse reactions
skin testing
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2020
2020
Historique:
received:
25
06
2020
accepted:
23
10
2020
entrez:
18
2
2021
pubmed:
19
2
2021
medline:
19
2
2021
Statut:
epublish
Résumé
Delayed drug hypersensitivity reactions are clinically diverse reactions that vary from isolated benign skin conditions that remit quickly with no or symptomatic treatment, drug discontinuation or even continued drug treatment, to the other extreme of severe cutaneous adverse reactions (SCARs) that are associated with presumed life-long memory T-cell responses, significant acute and long-term morbidity and mortality. Diagnostic "in clinic" approaches to delayed hypersensitivity reactions have included patch testing (PT), delayed intradermal testing (IDT) and drug challenges for milder reactions. Patch and IDT are, in general, performed no sooner than 4-6 weeks after resolution of the acute reaction at the maximum non-irritating concentrations. Functional
Identifiants
pubmed: 33597867
doi: 10.3389/fphar.2020.573573
pii: 573573
pmc: PMC7883592
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
573573Subventions
Organisme : NHGRI NIH HHS
ID : R01 HG010863
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW010559
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI152183
Pays : United States
Organisme : NIGMS NIH HHS
ID : P50 GM115305
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI139021
Pays : United States
Informations de copyright
Copyright © 2021 Copaescu, Gibson, Li, Trubiano and Phillips.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Br J Dermatol. 2013 Mar;168(3):539-49
pubmed: 23106791
Curr Allergy Asthma Rep. 2014 Jun;14(6):442
pubmed: 24740692
Ann Allergy Asthma Immunol. 2017 May;118(5):644-645
pubmed: 28477797
Allergy. 2003 Sep;58(9):854-63
pubmed: 12911412
J Am Acad Dermatol. 2014 Mar;70(3):539-48
pubmed: 24388722
Contact Dermatitis. 1996 Oct;35(4):234-6
pubmed: 8957644
Nature. 2012 Jun 28;486(7404):554-8
pubmed: 22722860
Clin Transl Allergy. 2013 Feb 01;3(1):3
pubmed: 23369181
J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1409-1411
pubmed: 29310902
J Invest Dermatol. 2000 Aug;115(2):149-53
pubmed: 10951229
J Antimicrob Chemother. 1975;1(3 Suppl):107-18
pubmed: 1201975
Clin Biochem Rev. 2013 Feb;34(1):15-38
pubmed: 23592889
JAMA Pediatr. 2016 Jun 6;170(6):e160033
pubmed: 27043788
N Engl J Med. 2013 Oct 24;369(17):1620-8
pubmed: 24152261
Allergy. 2009 Sep;64(9):1269-78
pubmed: 19254289
Tissue Antigens. 2004 Dec;64(6):631-49
pubmed: 15546336
Clin Exp Allergy. 1997 Feb;27(2):175-81
pubmed: 9061217
Allergol Int. 2018 Jan;67(1):90-95
pubmed: 28648978
J Allergy Clin Immunol. 2015 Aug;136(2):219-34; quiz 235
pubmed: 26254049
J Allergy Clin Immunol Pract. 2017 May - Jun;5(3):823-826
pubmed: 27888029
Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4134-9
pubmed: 15743917
J Allergy Clin Immunol. 2019 Jan;143(1):66-73
pubmed: 30573342
J Allergy Clin Immunol Pract. 2020 Mar;8(3):1142-1146.e4
pubmed: 31678298
J Allergy Clin Immunol Pract. 2019 Nov - Dec;7(8):2894-2897.e7
pubmed: 31100551
J Pharmacol Exp Ther. 2012 Jun;341(3):597-610
pubmed: 22371438
N Engl J Med. 2008 Feb 7;358(6):568-79
pubmed: 18256392
Br J Dermatol. 2005 May;152(5):968-74
pubmed: 15888154
J Dermatol Sci. 2013 Jan;69(1):38-43
pubmed: 23141052
Br J Dermatol. 2016 Nov;175(5):1106-1108
pubmed: 26265104
J Allergy Clin Immunol. 2003 Sep;112(3):629-30
pubmed: 13679828
Cleve Clin J Med. 1991 Jan-Feb;58(1):64-5
pubmed: 1829986
J Allergy Clin Immunol. 2013 Oct;132(4):981-3
pubmed: 23768571
Allergol Immunopathol (Madr). 2009 Mar-Apr;37(2):98-104
pubmed: 19445867
Pharmacogenomics J. 2006 Jul-Aug;6(4):265-8
pubmed: 16415921
Pol Arch Med Wewn. 2015;125(11):823-34
pubmed: 26445768
Br J Dermatol. 2012 Aug;167(2):452-3
pubmed: 22384988
Eur Cytokine Netw. 2008 Sep;19(3):131-41
pubmed: 18775806
Allergol Int. 2017 Jan;66(1):116-122
pubmed: 27497618
J Dermatol. 1990 Apr;17(4):235-9
pubmed: 2142173
J Allergy Clin Immunol. 2015 Apr;135(4):972-976
pubmed: 25457154
Acta Derm Venereol. 2012 May;92(3):307-12
pubmed: 22170236
J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1287-1296.e1
pubmed: 29100867
Br J Dermatol. 2013 Mar;168(3):555-62
pubmed: 23136927
Nat Med. 2008 Dec;14(12):1343-50
pubmed: 19029983
Contact Dermatitis. 2017 Nov;77(5):297-302
pubmed: 28730661
Am J Pathol. 2003 May;162(5):1515-20
pubmed: 12707034
J Allergy Clin Immunol. 2013 Mar;131(3):907-9
pubmed: 23083672
Int J Dermatol. 2016 Nov;55(11):1225-1233
pubmed: 27421110
Curr Opin Infect Dis. 2013 Dec;26(6):526-37
pubmed: 24126717
Int Arch Allergy Immunol. 2011;155(2):155-9
pubmed: 21196760
JAMA. 2017 Jul 4;318(1):82-83
pubmed: 28672303
Lancet. 2017 Oct 28;390(10106):1996-2011
pubmed: 28476287
Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):9959-64
pubmed: 22645359
Clin Exp Allergy. 2013 Sep;43(9):1027-37
pubmed: 23957338
J Am Acad Dermatol. 2002 Jul;47(1):58-62
pubmed: 12077582
J Investig Allergol Clin Immunol. 2014;24(6):425-30
pubmed: 25668894
Clin Exp Allergy. 2001 Sep;31(9):1398-408
pubmed: 11591190
Allergy. 2004 Aug;59(8):809-20
pubmed: 15230812
Contact Dermatitis. 2001 Dec;45(6):321-8
pubmed: 11846746
Lancet. 2002 Mar 2;359(9308):727-32
pubmed: 11888582
J Allergy Clin Immunol. 2016 Jul;138(1):179-186
pubmed: 27016799
Allergy. 2004 Feb;59(2):219-24
pubmed: 14763937
Ann Rheum Dis. 2015 Dec;74(12):2157-64
pubmed: 25115449
Int Arch Allergy Immunol. 2016;171(3-4):166-179
pubmed: 27960170
J Allergy Clin Immunol Pract. 2017 May - Jun;5(3):547-563
pubmed: 28483310
Eur J Immunol. 1996 Jan;26(1):42-8
pubmed: 8566082
Allergy. 2013 Jun;68(6):702-12
pubmed: 23617635
J Allergy Clin Immunol Pract. 2019 Nov - Dec;7(8):2722-2738.e5
pubmed: 31170539
J Investig Allergol Clin Immunol. 2014;24(5):331-7
pubmed: 25345303
Br J Clin Pharmacol. 2016 Jan;81(1):10-2
pubmed: 26286675
J Investig Allergol Clin Immunol. 2010;20(7):630-1
pubmed: 21314013
Acta Derm Venereol. 2013 Nov;93(6):753-4
pubmed: 23584150
Br J Dermatol. 2007 Mar;156(3):609-11
pubmed: 17300272
Eur Ann Allergy Clin Immunol. 2015 Nov;47(6):225-7
pubmed: 26549341
Allergy. 2009 Apr;64(4):534-42
pubmed: 19154548
Contact Dermatitis. 1999 Oct;41(4):185-9
pubmed: 10515095
Allergy. 2002 Jan;57(1):45-51
pubmed: 11991289
Allergy. 2010 Mar;65(3):376-84
pubmed: 19793058
J Eur Acad Dermatol Venereol. 2018 Jun;32(6):992-998
pubmed: 29478292
Curr Opin Allergy Clin Immunol. 2015 Aug;15(4):294-9
pubmed: 26110678
J Invest Dermatol. 2017 May;137(5):1065-1073
pubmed: 28011147
J Allergy Clin Immunol. 2002 Jan;109(1):155-61
pubmed: 11799383
J Cutan Pathol. 2001 Mar;28(3):113-9
pubmed: 11168761
J Allergy Clin Immunol. 2008 Nov;122(5):992-1000
pubmed: 18692887
Clin Ther. 2002 Oct;24(10):1502-14
pubmed: 12462283
Clin Dermatol. 2015 Jul-Aug;33(4):462-5
pubmed: 26051062
Clin Exp Allergy. 2008 Jan;38(1):185-90
pubmed: 17976216
Immunol Cell Biol. 2012 Feb;90(2):224-34
pubmed: 21577229
AIDS. 2002 Nov 8;16(16):2223-5
pubmed: 12409746
Nat Genet. 2009 Jul;41(7):816-9
pubmed: 19483685
J Allergy Clin Immunol. 2019 Jul;144(1):183-192
pubmed: 30776417
Contact Dermatitis. 2015 Oct;73(4):195-221
pubmed: 26179009
Int J Mol Sci. 2016 Nov 15;17(11):
pubmed: 27854302
J Allergy Clin Immunol Pract. 2016 Jan-Feb;4(1):158-9
pubmed: 26320832
Allergy. 2011 May;66(5):702-3
pubmed: 21470241
Curr Opin Infect Dis. 2016 Dec;29(6):561-576
pubmed: 27753687